ArticleFrontiers in oncology2024

Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study.

Ji Won Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.